Table 1

Demographic, clinical and psychosocial characteristics of the groups

Group; no. (%)*
CharacteristicCSA+, n = 22CSA−, n = 82Control, n = 20Statisticp value
Age, mean ± SD yr31.8 ± 6.228.1 ± 7.629.5 ± 8.8F2,120 = 2.120.12
Menstrual cycleχ22 = 0.420.80
 Follicular phase13 (59.1)47 (57.3)10 (50)
 Luteal phase9 (40.9)35 (42.6)10 (50)
Comorbidities
 Depressive episode6 (27.2)13 (15.8)χ21 = 1.350.24
 Bipolar disorder1 (4.5)11 (13.4)χ21 = 1.160.28
 Posttraumatic stress disorder5 (22.7)7 (8.5)χ21 = 2.980.08
 Other axis I disorder4 (18.1)8 (9.7)χ21 = 1.530.21
Medication
 Mood stabilizers10 (45.5)44 (53.7)χ21 = 0.460.49
 Neuroleptics10 (45.5)48 (58.5)χ21 = 1.210.27
 Antidepressants1 (4.5)7 (8.5)χ21 = 0.380.53
CTQ–CSA, mean ± SD18.31 ± 5.256.08 ± 2.52U = 98< 0.001
BMI, mean ± SD
 Baseline22.8 ± 3.122.3 ± 3.523.7 ± 3.2F2,121 = 1.400.24
 11 d23.7 ± 3.223.1 ± 3.7F2,121 = 0.430.65
 18 d24.3 ± 3.523.9 ± 3.4F2,121 = 0.140.86
  • BMI = Body Mass Index; CSA+ = crack cocaine dependence with a history of childhood sexual abuse; CSA− = crack cocaine dependence without a history of childhood sexual abuse; CTQ = Childhood Trauma Questionnaire; SD = standard deviation.

  • * Unless otherwise indicated.

  • U = Wilcoxon Mann Whitney test.

  • Phase of menstrual cycle during first week of hospitalization.